Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Clover Health Investments, Corp. (NASDAQ: CLOV)
CLOV Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-60.30%
CLOV Stock Analysis
CLOV
PE Ratio:
CLOV
PEG Ratio:
Not Available
CLOV
Forward EPS Growth (12 month):
0.00%
CLOV
PS Ratio:
0.9
CLOV
PSG Ratio:
0.1
CLOV
Forward Revenue Growth (12 month):
14.20%
CLOV Articles
No data was found